Our CU Lymphoma Program faculty Dr. Ajay Major, MD, MBA contributed to the development of the LP-IPS prognostic score in NLPHL, now published in Journal of Clinical Oncology as part of the multinational GLOW: Global nLPHL One Working Group research consortium. #lymsm #nlphlsm ascopubs.org/doi/10.1200/JC…

Long term remission. Marc Schwartz, MD helped Codie Mendez get to this wonderful place of long term remission with a bone marrow transplant.

What's new in CAR-T from #ASCO24? ☑️ Liso-Cel NCP shows Safety, Clinical Benefit in #LBCL ☑️ Dr. Lakshmi Nayak of Dana-Farber Shares Pilot Data on Axi-Cel in CNS #Lymphoma ☑️ manalikamdar Talks Liso-Cel in B-Cell Lymphomas in TRANSFORM Study and more! buff.ly/3u19Xpa

New cafe at CU Anschutz Medical Campus, over by Bioscience 3. 100% of profits support people experiencing homelessness. M-F 7a-2p. maps.app.goo.gl/qLCtUpmBBzmXL3…

Our CU Lymphoma Program chair Dr. manalikamdar contributed to the ASTCT / The EBMT collaborative clinical practice guidelines, now published Transplantation and Cellular Therapy Journal. #celltherapy #bmtsm pubmed.ncbi.nlm.nih.gov/38972511/

Our CU Lymphoma Program T/NK-cell expert Dr. Brad Haverkos contributed to a CIBMTR analysis of CAR-T outcomes in complete remission, now published Leukemia Journal. #lymsm #celltherapy nature.com/articles/s4137…

New publication from the CU Lymphoma Program group with Dr. Meryl Colton, MD MSc as first author: the use of MRD monitoring to predict outcomes after tisa-cel in R/R DLBCL. #lymsm #celltherapy cc Brad Haverkos StevenBairMD manalikamdar pubmed.ncbi.nlm.nih.gov/39034202/

🚨See table of strengths of the GHSG HD21 study for untreated advanced-stage classic #HodgkinLymphoma (cHL) & remaining opportunities in the field. ➡️Therapy for cHL has undergone a remarkable evolution over the past 60 yrs since development of MOPP in 1964 w/ 50% OS (now >95%!)

A warm welcome to Dr. Mat Angelos who is joining our CU Anschutz Division of Hematology leukemia program as an assistant professor. cc CU Department of Medicine CU Cancer Center #leusm

Welcome to Dr. Haley Simpson who will be joining our CU Anschutz Division of Hematology myeloma team as an instructor. cc Daniel Sherbenou, MD, PhD CU Anschutz Hematology/Oncology Fellowship CU Department of Medicine #mmsm

.Mat Angelos a warm welcome, indeed. See you soon -- in just 3 days!!

Interested in how you can incorporate patient-reported outcomes (PROs) into your hematology clinical trials to measure treatment tolerability? Check out our latest review, with PRO gurus Drs. Amylou Dueck, PhD & Gita Thanarajasingam. #lymsm #leusm #mmsm clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

New publication from the CU Anschutz Division of Hematology group including our lymphoma transplanter Brad Haverkos about outcomes of haplo-cord versus dual-cord transplants. #bmtsm cc Maria Amaya, MD PhD Rachel Rabinovitch Sarah Milgrom, MD Daniel Pollyea sciencedirect.com/science/articl…

Our CU Lymphoma Program chair manalikamdar is co-author of a new review in IJROBP - The Red Journal discussing the NIVAHL, AHOD1331, and pembro-GVD trials in Hodgkin lymphoma. #lymsm #radonc cc Sarah Milgrom, MD CU Anschutz Division of Hematology redjournal.org/article/S0360-…

CU Cancer Center Benjamin Brewer, PsyD, has been awarded a $1.55 million R25 grant from National Cancer Institute to develop a nationwide training program to help clinicians use the latest digital tools. Learn more ⬇️ news.cuanschutz.edu/cancer-center/…

Welcome to Jorge Monge, MD who is joining our CU Anschutz Division of Hematology myeloma division! #mmsm cc CU Cancer Center CU Department of Medicine

Made a new friend CU Anschutz Medical Campus today while on service! #bmtsm #colorado

New publication featuring our CU Lymphoma Program faculty Drs. manalikamdar & Brad Haverkos in Blood Advances about outcomes of HGBL, NOS with CNS involvement. Congratulations to Dr. Narendranath Epperla et al. #lymsm pubmed.ncbi.nlm.nih.gov/39189932/

It was a pleasure hosting the brilliant Ajay Major, MD, MBA and learning all about the current and future applications of PROs. A very important topic for both trials and clinical care- thank you, Dr. Major, for the stellar talk and discussions. Yale Cancer Center YaleHematology Yale COPPER Center

Help new patients and their loved ones understand diagnoses by sharing educational videos! #CUAnschutz CU Cancer Center We recently added 2 short videos to the Division's website. Our providers describe AML and DLBCL here (both English & Spanish): bit.ly/CUPatientResou…